Offline Showroom in USA
Post Offer Free
MOSINTER GROUP LIMITED
MOSINTER GROUP LIMITED  

Gold Index: 82941

You are here: home  > Pharmaceutical Chemicals API  > Digestive System Drugs API  > Ranitidine hydrochloride CAS 66357-35-5 Sostri Taural Terposen Trigger

Ranitidine hydrochloride CAS 66357-35-5 Sostri Taural Terposen Trigger 

Payment Terms: T/T,L/C,WU 
Place of Origin: Shandong, China (Mainland) 
inquire skype
Add to My Favorites
HiSupplier Escrow
Share |

Product Detail

Model No.: MOSINTER
Production Capacity: 100Ton/Year
Delivery Date: Within 7 days
Means of Transport: Ocean,Land,Air
Packing: According to the request of...
cas: 66357-35-5

Relief of heartburn, acid indigestion, and sour stomach.
Short-term and maintenance therapy of gastric and duodenal ulcers

Ranitidine hydrochloride ( CAS: 66357-35-5)


Item

Index

Molecular Formula

C13H22N4O3S

Molecular weight

314.4

Specification

CP/USP/EP

Appearance

Off-white or   light yellow  crystalline powder

Melting point

69-70°C

Solubility (in water)

24.7 mg/mL

Storage Condition

Desiccate at +4°C

 

Ranitidine is a histamine H2-receptor antagonist that inhibits stomach acid production. It is commonly used in treatment of peptic ulcer disease (PUD) and gastroesophageal reflux disease (GERD). Ranitidine is also used alongside fexofenadine and other antihistamines for the treatment of skin conditions such as hives. Ranitidine is also known to give false positives for methamphetamine on drug tests.

It is on the World Health Organization's List of Essential Medicines, a list of the most important medication needed in a basic health system.

Medical use

Relief of heartburn, acid indigestion, and sour stomach.

Short-term and maintenance therapy of gastric and duodenal ulcers

Ranitidine can also be coadministered with NSAIDs to reduce the risk of ulceration. Proton-pump inhibitors (PPIs) are more effective for the prevention of NSAID-induced ulcers.

Pathologic GI Hypersecretory Conditions such as Zollinger-Ellison Syndrome

Gastroesophageal Reflux (GERD)

erosive esophagitis

Part of a multidrug regimen for H. pylori eradication to reduce the risk of duodenal ulcer recurrence.

Recurrent postoperative ulcer

Upper GI bleeding

Prevention of acid-aspiration pneumonitis during surgery: Ranitidine can be administered preoperatively to reduce the risk of aspiration pneumonia. The drug not only increases gastric pH, but also reduces the total output of gastric juice. In a 2009 meta-analysis comparing the net benefit of proton pump inhibitors and ranitidine to reduce the risk of aspiration before anesthesia, ranitidine was found to be more effective than proton pump inhibitors in reducing the volume of gastric secretions. Ranitidine may have an antiemetic effect when administered preoperatively.

Prevention of stress-induced ulcers in critically ill patients.Ranitidine is a histamine H2-receptor antagonist that inhibits stomach acid production. It is commonly used in treatment of peptic ulcer disease (PUD) and gastroesophageal reflux disease (GERD). Ranitidine is also used alongside fexofenadine and other antihistamines for the treatment of skin conditions such as hives. Ranitidine is also known to give false positives for methamphetamine on drug tests.

It is on the World Health Organization's List of Essential Medicines, a list of the most important medication needed in a basic health system.

Medical use

Relief of heartburn, acid indigestion, and sour stomach.

Short-term and maintenance therapy of gastric and duodenal ulcers

Ranitidine can also be coadministered with NSAIDs to reduce the risk of ulceration. Proton-pump inhibitors (PPIs) are more effective for the prevention of NSAID-induced ulcers.

Pathologic GI Hypersecretory Conditions such as Zollinger-Ellison Syndrome

Gastroesophageal Reflux (GERD)

erosive esophagitis

Part of a multidrug regimen for H. pylori eradication to reduce the risk of duodenal ulcer recurrence.

Recurrent postoperative ulcer

Upper GI bleeding

Prevention of acid-aspiration pneumonitis during surgery: Ranitidine can be administered preoperatively to reduce the risk of aspiration pneumonia. The drug not only increases gastric pH, but also reduces the total output of gastric juice. In a 2009 meta-analysis comparing the net benefit of proton pump inhibitors and ranitidine to reduce the risk of aspiration before anesthesia, ranitidine was found to be more effective than proton pump inhibitors in reducing the volume of gastric secretions. Ranitidine may have an antiemetic effect when administered preoperatively.

Prevention of stress-induced ulcers in critically ill patients.

bigPhoto
skype Mr. Fedor

Tel: +86-574-89212210
Fax: +86-574-89212215
Mobile: 86- 189 8930 5995
Contact to this supplier

Didn't find what you're looking for? Post Buying Lead or contact HiSupplier Customer Service Center  for help!

Related Search

Find more related products in following catalogs on Hisupplier.com

Company Info

MOSINTER GROUP LIMITED [China (Mainland)]

Offline Showroom in USA

Business Type:Manufacturer, Trading Company
City: Ningbo
Province/State: Zhejiang
Country/Region: China (Mainland)

Follow Us: Follow us on facebook Follow us on linkedin

Fedor:   skype

You May Like: